NY-ESTÉE-LAUDER
16.7.2024 07:31:34 CEST | Business Wire | Press release
The Estée Lauder Companies (NYSE: EL) (“ELC”) is pleased to announce the third edition of BEAUTY&YOU India. Created by ELC’s New Incubation Ventures (“NIV”) and launched in partnership with India’s preferred beauty and lifestyle retailer - NYKAA, BEAUTY&YOU India continues its mission to discover, spotlight, and propel the next generation of India-focused beauty brands. The program supports India-focused companies, entrepreneurs, innovators, and creators through a competitive application process that will be open to prospective applicants on July 16, 2024, through August 29, 2024, via www.beautyandyouawards.com. Winners will be announced on November 16, 2024, at a live event in Goa.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240715092980/en/
Introducing BEAUTY&YOU India 2024: Fueling Innovation in the Indian Beauty Landscape (Photo: Business Wire)
The 2024 program builds on the success of previous years with the theme of Supercharged Futures. The beauty opportunity in India continues to grow with more brands, increased innovation, significant investment dollars, and a consumer base looking for the best solutions. BEAUTY&YOU India 2024 seeks applicants with a supercharged vision for the future of Indian beauty and its impact on the broader beauty ecosystem. This encompasses companies with social initiatives that enhance the lives of their communities and the ecosystems in which they operate. It also includes founders who are developing new technologies, ingredients, or solutions that address existing challenges for Indian beauty consumers while driving innovation across Skin Care, Makeup, Hair Care and Fragrance categories.
An exciting addition to this year's program is that winners will have access to the BEAUTY&YOU India Bootcamp, featuring one-on-one mentorship sessions with industry leaders Falguni Nayar, Founder & Chief Executive Officer, NYKAA; Sabyasachi Mukherjee, Founder, Sabyasachi; and Rohan Vaziralli, General Manager, ELCA Cosmetics Private Limited. This unique opportunity is designed to provide the winners with invaluable insights and mentorship from these experts and affirms the program’s commitment to fostering the growth and development of the next generation of Indian-focused beauty entrepreneurs.
From the first edition in 2022 to the second in 2023, the applicant pool doubled in size. This growth has significantly enhanced the visibility and opportunities for the winners, underscoring the program's positive impact.
“India represents one of the most exciting global economies for beauty today. A growing consumer base, an exciting retail landscape, and one of the most powerful entertainment markets in the world continue to fuel unprecedented growth. The market is poised to continue to drive both national and global trends. We are excited to support the founders and creators in their journey,” said Shana Randhava, Senior Vice President, New Incubation Ventures, ELC.
"The global recognition of India’s potential as both a powerful consumer market and entrepreneurial hub is more evident now than ever before. NYKAA is proud to be a part of nurturing this ecosystem,” said Anchit Nayar, Executive Director & CEO, NYKAA Beauty. “In its third edition, BEAUTY&YOU India is more than just a platform — it's a gateway for Indian entrepreneurs to showcase their creativity and rigor on a global stage and we are excited to be part of their future.”
"Participating in BEAUTY&YOU India since its first edition has been an immensely rewarding experience, particularly in seeing its transformative impact on the Indian beauty industry. The program enhances the trajectory of emerging brands by providing a platform that fosters growth, innovation, and visibility,” said 2024 BEAUTY&YOU India judge Katrina Kaif, Actor and Co-Founder, Kay Beauty, “In my role as the co-founder of Kay Beauty, I have a deep appreciation for such platforms that support entrepreneurs in their journey. As we enter the third edition, I am as excited and committed as ever to discover and support brands that are shaping the future of beauty in India."
2024 Prize Program
The following prizes are open to founders, companies, and creatives meeting specific application criteria available at www.beautyandyouawards.com/application-criteria. The following awards will be presented across categories in Skin Care, Make Up, Hair Care, Personal Fragrance, and Home Fragrance:
- IMAGINE: Pre-Launch Beauty Concepts
- GROW: In-Market Beauty Concepts
- CREATE: The Next Generation of Creative Talent (e.g., photographers, filmmakers, etc.) Submitting Work Around the Theme of ‘Supercharged Futures’
Among other resources, BEAUTY&YOU India 2024 will provide award recipients with financial support (a prize pool up to 4 Crore or $500k), distribution channel access, mentorship, and access to research and innovation resources.
The BEAUTY&YOU 2024 website and application portal go live July 16, 2024, and will accept applications until August 29, 2024, 11:59 PM IST. Full program details are available at www.beautyandyouawards.com.
2024 Judges
Shana Randhava
Senior Vice President, New Incubation Ventures, The Estée Lauder Companies
Anchit Nayar
Executive Director & CEO, NYKAA Beauty
Katrina Kaif
Actor and Co-Founder, Kay Beauty
Gaurav Gupta
Couturier, Artist and Designer
Anaita Shroff Adajania
Stylist, Creative Director & Founder, Style Cell
Samrath Bedi
Executive Director, Forest Essentials
Diipa Büller-Khosla
Founder, indē wild
Sandhya Devanathan
Vice President & Head – India, Meta
Rohan Vaziralli
General Manager, ELCA Cosmetics Private Limited
Jaffrey Zaman
Managing Director, Intercos India Private Limited
Gianandrea Ferrari
CEO, Intercos Europe, Middle East & India
Sumit Bhasin
Senior Vice President, Global Fragrance Innovation, Product Development & R&D, The Estée Lauder Companies
Dr. Jaishree Sharad
Celebrated Cosmetic Dermatologist, author and TEDx Speaker
Shruti Chandra,
Vice President, Invest India and Vice Chair, Women Empowerment, Europe India Council for Business and Industry (EICBI)
Rochelle Pinto
Head of Editorial Content, Vogue India
Sujata Assomull
Contributing Editor, Vogue Business
Deepica Mutyala
Founder and CEO, Live Tinted
About BEAUTY&YOU India
BEAUTY&YOU aims to help founders, innovators and creators grow their businesses holistically by identifying brand goals, achieving scale ambitions and curating product portfolios that speak to a new generation of Indian consumers.
About The Estée Lauder Companies’ New Incubation Ventures
New Incubation Ventures (NIV) is the strategic early-stage investment and incubation arm for The Estée Lauder Companies. NIV partners with forward-thinking founders and entrepreneurs to create, fund, and support the best-emerging beauty brands and new business models to shape the future of beauty and build an actionable pipeline of diversified brands and new engines of growth for the ELC portfolio.
About The Estée Lauder Companies
The Estée Lauder Companies Inc. is one of the world’s leading manufacturers, marketers, and sellers of quality skin care, makeup, fragrance, and hair care products, and is a steward of luxury and prestige brands globally. The company’s products are sold in approximately 150 countries and territories under brand names including: Estée Lauder, Aramis, Clinique, Lab Series, Origins, M·A·C, La Mer, Bobbi Brown Cosmetics, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, KILIAN PARIS, Too Faced, Dr.Jart+, and the DECIEM family of brands, including The Ordinary and NIOD.
About NYKAA
Born out of a desire to make beauty a mainstream choice, Nykaa began in 2012 as a digitally native, consumer-tech company. Through founder Falguni Nayar’s vision to bring inspiration and joy to people everywhere, it tapped into an underserved beauty retail market, disrupting the ecosystem and putting India in the global spotlight. Today, Nykaa has expanded its offerings to include lifestyle and B2B by introducing online platforms Nykaa Fashion, Nykaa Man and Superstore.
Over the years, Nykaa has steadily captured the hearts of Indian consumers, ushering visits to its online and 175 offline destinations and building loyal communities through engaging and educational content. Nykaa continues to build its house of brands with a sharp focus on innovation and consumer delight. Beauty brands such as Kay Beauty, Nykaa Naturals, Nykaa Cosmetics and Wanderlust along with fashion brands such as Nykd, Gajra Gang, Likha, RSVP and Pipa Bella have become household names as they consistently deliver inspiration and high-performing products to the consumers.
Nykaa’s unwavering commitment to authenticity and putting the customer at the heart of everything that they do has made it the retailer of choice for international brands entering India. Its Global Store, a gateway into the world of coveted international brands, leverages the company’s proven supply chain and marketing capabilities to offer a truly seamless shopping experience.
Website: www.beautyandyouawards.com
Instagram: @beautyandyouawards
ELC-C
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240715092980/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release
Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release
The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release
Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
